Amphastar Pharmaceuticals Return on Tangible Equity 2012-2025 | AMPH

Current and historical return on tangible equity values for Amphastar Pharmaceuticals (AMPH) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Amphastar Pharmaceuticals Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $0.14B $0.17B 101.81%
2024-12-31 $0.16B $0.14B 140.71%
2024-09-30 $0.16B $0.13B 186.90%
2024-06-30 $0.17B $0.11B 370.95%
2024-03-31 $0.15B $0.07B 1987.10%
2023-12-31 $0.14B $0.03B 114.88%
2023-09-30 $0.14B $-0.02B 57.32%
2023-06-30 $0.10B $-0.04B 28.45%
2023-03-31 $0.09B $0.51B 19.25%
2022-12-31 $0.09B $0.49B 19.55%
2022-09-30 $0.08B $0.47B 17.32%
2022-06-30 $0.09B $0.46B 21.40%
2022-03-31 $0.08B $0.44B 19.69%
2021-12-31 $0.06B $0.41B 15.40%
2021-09-30 $0.04B $0.39B 9.04%
2021-06-30 $0.01B $0.43B 2.66%
2021-03-31 $0.00B $0.41B 0.74%
2020-12-31 $0.00B $0.41B 0.50%
2020-09-30 $0.01B $0.41B 1.77%
2020-06-30 $0.00B $0.40B 1.02%
2020-03-31 $0.05B $0.38B 13.39%
2019-12-31 $0.05B $0.39B 13.00%
2019-09-30 $0.05B $0.39B 14.40%
2019-06-30 $0.05B $0.39B 15.70%
2019-03-31 $0.00B $0.34B 0.65%
2018-12-31 $-0.01B $0.32B -2.03%
2018-09-30 $-0.01B $0.30B -2.44%
2018-06-30 $-0.01B $0.28B -3.18%
2018-03-31 $0.00B $0.28B -1.40%
2017-12-31 $0.00B $0.29B 1.40%
2017-09-30 $0.00B $0.29B 0.00%
2017-06-30 $0.00B $0.29B 1.42%
2017-03-31 $0.01B $0.28B 3.27%
2016-12-31 $0.01B $0.28B 3.73%
2016-09-30 $0.02B $0.28B 8.00%
2016-06-30 $0.01B $0.26B 5.51%
2016-03-31 $0.00B $0.25B 0.00%
2015-12-31 $0.00B $0.26B -1.22%
2015-09-30 $-0.01B $0.24B -5.81%
2015-06-30 $-0.02B $0.24B -6.66%
2015-03-31 $-0.01B $0.24B -4.15%
2014-12-31 $-0.01B $0.24B -4.69%
2014-09-30 $-0.01B $0.24B -2.63%
2014-06-30 $0.00B $0.25B -0.60%
2014-03-31 $0.01B $0.21B 7.57%
2013-12-31 $0.01B $0.21B 22.75%
2013-09-30 $0.01B 29.32%
2013-06-30 $0.02B 35.60%
2013-03-31 $0.01B 29.32%
2012-12-31 $0.02B $0.19B 37.70%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $1.225B $0.732B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.381B 7.28
Dr Reddy's Laboratories (RDY) India $12.981B 23.56
BridgeBio Pharma (BBIO) United States $7.333B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.856B 15.07
Bausch Health Cos (BHC) Canada $1.762B 1.27
Taysha Gene Therapies (TSHA) United States $0.610B 0.00
Personalis (PSNL) United States $0.460B 0.00
Assembly Biosciences (ASMB) United States $0.124B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00